Integral Diagnostics Limited (OTCMKTS:ITGDF) Short Interest Update

Integral Diagnostics Limited (OTCMKTS:ITGDF) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 1,858,369 shares, an increase of 42.7% from the December 15th total of 1,302,385 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Integral Diagnostics Stock Performance

OTCMKTS ITGDF opened at $1.00 on Friday. The business’s 50-day moving average price is $1.00 and its 200 day moving average price is $1.36. Integral Diagnostics has a twelve month low of $0.96 and a twelve month high of $2.10.

Integral Diagnostics Company Profile

Integral Diagnostics (OTCMKTS:ITGDF) is an Australia-based provider of comprehensive diagnostic imaging services, operating a network of advanced medical imaging facilities across Australia and New Zealand. The company offers a broad range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, nuclear medicine, positron emission tomography (PET) scanning and interventional radiology. Integral Diagnostics supports both hospital-based and standalone imaging centres, catering to a diverse patient base that includes outpatient clinics, public hospitals and private practitioners.

Founded through the consolidation of several independent radiology practices, Integral Diagnostics took its current form following an initial public offering on the Australian Securities Exchange in 2013.